2.34
Finanzdaten der Boundless Bio Inc-Aktie (BOLD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
68.46%
24.38
|
14.47 | 14.00 | 15.15 | 17.06 |
| Depreciation and Amortization |
333.33%
1.30
|
0.30 | 0.40 | 0.30 | 0.30 |
| Operating Income/Loss |
68.46%
-24.38
|
-14.47 | -14.00 | -15.15 | -17.06 |
| Nonoperating Income/Loss |
24.89%
0.691
|
0.92 | 1.117 | 1.269 | 1.386 |
| Net Income/Loss |
74.79%
-23.69
|
-13.55 | -12.88 | -13.88 | -15.68 |
| Basic Average Shares |
0.19%
22.45
|
22.41 | 0.013 | 22.39 | 22.36 |
| Diluted Average Shares |
0.19%
22.45
|
22.41 | 0.013 | 22.39 | 22.36 |
| Basic Earnings Per Share |
76.67%
-1.06
|
-0.60 | -0.57 | -0.62 | -0.70 |
| Diluted Earnings Per Share |
76.67%
-1.06
|
-0.60 | -0.57 | -0.62 | -0.70 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):